A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis.

Clinical trial NCT07318675 · RECRUITING

Trial details

NCT number: NCT07318675
Sponsor: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Actinic Keratosis (AK)

Start date: 2025-12-25
Primary completion: 2026-03-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.